Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.
Open Access
- 1 May 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 73 (5) , 1335-1343
- https://doi.org/10.1172/jci111336
Abstract
Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyrodism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared beta-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the beta-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors less than 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P less than 0.02) to the right as a result of a significant (P less than 0.01) decrease in the percent of beta-adrenergic receptors in the high affinity state from 64 +/- 22% in PHP-Ib and 56 +/- 5% in controls to 10 +/- 8% in PHP-Ia. The agonist competition curves were computer fit to a "ternary complex" model for the two-step reaction: H + R + N in equilibrium HR + N in equilibrium HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H. E., and A. S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, whereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.This publication has 34 references indexed in Scilit:
- Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. A cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cellsJournal of Clinical Investigation, 1983
- Resistance to multiple hormones in patients with pseudohypoparathyroidismThe American Journal of Medicine, 1983
- Demonstration of human platelet β-adrenergic receptors using 125I-labeled cyanopindolol and 125I-labeled hydroxybenzylpindololBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982
- Molecular Mechanisms of Coupling in Hormone Receptor‐Adenylate Cyclase SystemsPublished by Wiley ,1982
- Hypothyroidism modulates beta adrenergic receptor adenylate cyclase interactions in rat reticulocytes.Journal of Clinical Investigation, 1981
- Defect of Receptor–Cyclase Coupling Protein in PseudohypoparathyroidismNew England Journal of Medicine, 1980
- Altered activity of the nucleotide regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism.Journal of Clinical Investigation, 1978
- Prolactin Deficiency in PseudohypoparathyroidismNew England Journal of Medicine, 1977
- Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.Journal of Clinical Investigation, 1976
- Pseudohypoparathyroidism: defective excretion of 3′,5′-AMP in response to parathyroid hormoneJournal of Clinical Investigation, 1969